Copyright
©The Author(s) 2025.
World J Gastrointest Endosc. May 16, 2025; 17(5): 105158
Published online May 16, 2025. doi: 10.4253/wjge.v17.i5.105158
Published online May 16, 2025. doi: 10.4253/wjge.v17.i5.105158
Table 3 The effect of endoscopic gastroplasty vs other interventions on total body weight loss
Ref. | Country | Number of studies & participants | Intervention and comparator | Effect measure | Effect size (95%CI) | Interpretation with respect to intervention |
3 months | ||||||
Brunaldi et al[14], 2018 | Brazil | 8 studies; 320 participants | FTS-APC vs FTS-alone | % mean | FTS-APC: 25.0 ± 1.99; FTS-alone: 15.3 ± 9.88 | The FTS-APC group and demonstrated significantly a greater weight loss compared to FTS alone (P < 0.001) |
Jaruvongvanich et al[11], 2020 | United States | 2 studies | ft-TORe vs APMC-TORe | % mean difference | -0.1 (-4.6 to 4.4) | There was no significant difference between two treatments |
Jaruvongvanich et al[11], 2020 | United States | 2 studies | TORe vs TORe-gastroplasty | % mean difference | 2.6 (0.5 to 4.7) | The TORe group and demonstrated significantly a greater weight loss compared to TORe-gastroplasty |
6 months | ||||||
Singh et al[9], 2020 | United States | 1 study; 58 participants | ESG vs IGB | % mean difference | 3.07 (1.46–4.67) | ESG achieved significantly (P = 0.002) superior weight loss compared to IGB |
Jalal et al[10], 2020 | Australia | 2 studies; 348 participants | ESG vs LSG | % mean difference | 8.52 (6.35–0.69) | LSG appeared to have a significantly (P < 0.00001) superior weight loss compared to ESG |
Jaruvongvanich et al[11], 2020 | United States | 3 studies | ft-TORe vs APMC-TORe | % mean difference | 0.3 (-5.5 to 6.0) | There was no significant difference between two treatments |
Jaruvongvanich et al[11], 2020 | United States | 2 studies | TORe vs TORe-gastroplasty | % mean difference | 0.8 (-2.3 to 3.9) | There was no significant difference between two treatments |
12 months | ||||||
Singh et al[9], 2020 | United States | 1 study; 58 participants | ESG vs IGB | % mean difference | 7.33 (5.22-9.44) | ESG achieved significantly (P = 0.0001) superior weight loss compared to IGB |
Mohan et al[13], 2020 | United States | 9 studies | ESG vs LSG | % mean | ESG: 17.08 (15.05-19.10); LSG: 30.5 (27.4-33.5) | LSG appeared to have a significantly (P = 0.001) superior weight loss compared to ESG |
Madruga-Neto et al[4], 2018 | Brazil | 2 studies; 376 participants | EG vs Sham | % mean difference | 4.8 (1.1-8.51) | The difference between the groups was significantly (P = 0.01) higher in the intervention group than in the control group |
18-24 months | ||||||
Singh et al[9], 2020 | United States | 1 study; 58 participants | ESG vs IGB | % mean difference | 11.51 (5.33-17.69) | ESG achieved significantly (P = 0.0003) superior weight loss compared to IGB |
- Citation: Abdulla M, Mohammed N, AlQamish J, Arau RT. Efficacy and safety of endoscopic gastroplasty for treatment of obesity: An overview of comparative meta-analyses. World J Gastrointest Endosc 2025; 17(5): 105158
- URL: https://www.wjgnet.com/1948-5190/full/v17/i5/105158.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i5.105158